Concepedia

Victor Pântea

VP

15

Publications

807

Citations

13

H-Index

2015

Active since

Affiliations

Nicolae Testemițanu State University of Medicine and Pharmacy(Current)

University of Duisburg-Essen

Université Paris Cité

Northeastern University

Sorbonne Université

Victor Pântea is an author at Nicolae Testemițanu State University of Medicine and Pharmacy specializing in viral hepatitis, hepatitis, and medicine.

ORCID

Top concepts

Publications per year

2015–2024

15

Publications

15

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

Michel Bazinet, Victor Pântea, Valentin Cebotarescu et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 246 citations · Full text

Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy

Michel Bazinet, Victor Pântea, Gheorghe Plăcintă et al. · Gastroenterology · 2020 · 218 citations · Full text

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection

Michel Bazinet, Victor Pântea, Valentin Cebotarescu et al. · Hepatology Communications · 2020 · 81 citations · Full text

Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D

Tarik Asselah, Vladimir Chulanov, Pietro Lampertico et al. · New England Journal of Medicine · 2024 · 59 citations · Full text

Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg

Louis Shekhtman, Scott J. Cotler, Leeor Hershkovich et al. · Scientific Reports · 2020 · 32 citations · Full text

Rows per page

1–5 of 15